The impact of post-remission granulocyte colony-stimulating factor use in the phase 3 studies of venetoclax combination treatments in patients with newly diagnosed acute myeloid leukemia.
作者信息
DiNardo Courtney D, Pratz Keith W, Panayiotidis Panayiotis, Wei Xudong, Vorobyev Vladimir, Illés Árpád, Kim Inho, Ivanov Vladimir, Ku Grace, Miller Catherine L, Zhang Meng, Tatsch Fernando, Potluri Jalaja, Schmidt Xenia, Récher Christian
机构信息
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
出版信息
Am J Hematol. 2025 Jan;100(1):185-188. doi: 10.1002/ajh.27515. Epub 2024 Nov 1.
Abstract
摘要
Zotero 插件